You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selinexor

Showing 1 - 25 of 83
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)

Recruiting
  • EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
  • Selinexor
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
  • +1 more
Nov 10, 2022

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • Selinexor
  • (no location specified)
Oct 27, 2022

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Selinexor
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 30, 2021

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Selinexor
  • +5 more
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

Withdrawn
  • Solid Tumor Malignancy
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
Dec 14, 2021

Extramedullary Multiple Myeloma Trial in Wuhan (Selinexor, CT103A)

Recruiting
  • Extramedullary Multiple Myeloma
  • Wuhan, Hu Bei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Selinexor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)

Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • selinexor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 27, 2023

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Selinexor
  • +3 more
  • Los Angeles, California
  • +2 more
Jun 2, 2022

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Selinexor
  • +3 more
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Selinexor
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Selinexor
  • Matching Placebo for selinexor
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Recruiting
  • Myeloma Multiple
  • +2 more
  • Selinexor
  • +3 more
  • Brooklyn, New York
  • +1 more
Jan 20, 2022

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Selinexor
  • +2 more
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Choline Salicylate
  • Selinexor
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 4, 2022

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jul 2, 2022

Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)

Recruiting
  • Sarcoma,Soft Tissue
  • Selinexor
  • Barcelona, Spain
  • +5 more
Nov 16, 2021

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Selinexor
  • +5 more
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

Not yet recruiting
  • AML, Adult
  • Selinexor
  • +2 more
  • Hangzhou, China
  • +3 more
Feb 12, 2023

Refractory Multiple Myeloma Trial in United States (selinexor, carfilzomib, dexamethasone)

Recruiting
  • Refractory Multiple Myeloma
  • selinexor
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Apr 1, 2022

B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)

Completed
  • B-cell Lymphoma
  • selinexor
  • +6 more
  • Bruxelles, Belgium
  • +7 more
Dec 6, 2021